Efforts to Revive Antibiotic Development With PASTEUR Act, Education, Awareness

Efforts to revive antibiotic development through the PASTEUR Act focus on combining policy incentives, education, and awareness to address the broken antibiotic market, where low financial returns have driven major pharma out of the field. The AMR Action Fund supports this indirectly by educating policymakers and the public on both the clinical importance of antibiotics and the economic barriers to innovation, while demonstrating that sustainable funding models can stimulate R&D. However, progress is slow due to the high upfront costs, limited urgency perception of AMR, and policy complexity, meaning that no single initiative will suffice—coordinated global action, aligned incentives, and continued advocacy are essential to rebuild a viable antibiotic pipeline.